elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598
Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
P2860
Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42698900-7D3B0F22-8AA6-439E-A3E4-2038E661A598
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
07b7d2c4be5a3af2ce5b7a6c92f9ab6bcbf788b6
P2860
Old medications and new targeted therapies in systemic sclerosis.